Reduced production of sulfated glycosaminoglycans occurs in Zambian children with kwashiorkor but not marasmus

American Journal of Clinical Nutrition

Volumn 89, Issue 2, 2009, Pages 592-600

  Amadi, Beatrice ^a   Fagbemi, Andrew O ^b   Kelly, Paul ^c,d   Mwiya, Mwiya ^a   Torrente, Franco ^b   Salvestrini, Camilla ^b   Day, Richard ^e   Golden, Michael H ^f   Eklund, Erik A ^g   Freeze, Hudson H ^g   Murch, Simon H ^h  

^a Department of Paediatrics and Child Health   (Zambia)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF ZAMBIA   (Zambia)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

^g BURNHAM INSTITUTE   (United States)

^h UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD3 ANTIGEN; CORE PROTEIN; GLYCOSAMINOGLYCAN POLYSULFATE; HLA DR ANTIGEN; PROTEOHEPARAN SULFATE; SYNDECAN 1;

ARTICLE; CELL DENSITY; CELL POPULATION; CHILD; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROL GROUP; CONTROLLED STUDY; DUODENUM BIOPSY; EPITHELIUM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFLAMMATION; INFLAMMATORY CELL; INTESTINE CELL; KWASHIORKOR; LAMINA PROPRIA; MALE; MARASMUS; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; UNITED KINGDOM; ZAMBIA;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DUODENUM; EDEMA; FEMALE; GLYCOSAMINOGLYCANS; HEPARAN SULFATE PROTEOGLYCANS; HIV INFECTIONS; HUMANS; INFANT; INFLAMMATION; KWASHIORKOR; MALE; PREVALENCE; PROTEIN-ENERGY MALNUTRITION; PROTEIN-LOSING ENTEROPATHIES; ZAMBIA;

EID: 59649101628     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.27092     Document Type: Article

References (50)

1. Golden MH. Edematous malnutrition. Br Med Bull 1998;54:433-44.
2. Amadi B, Kelly P, Mwiya M, et al. Intestinal and systemic infection, HIV, and mortality in Zambian children with persistent diarrhea and malnutrition. J Pediatr Gastroenterol Nutr 2001;32:550-4.
3. Courtright P, Canner J. The distribution of kwashiorkor in the southern region of Malawi. Ann Trop Paediatr 1995;15:221-6.
4. Manary MJ, Brewster DR. Intensive nursing of kwashiorkor in Malawi. Acta Paediatr 2000;89:203-7.
5. Gopalan C. Kwashiorkor and marasmus: evolution and distinguishing features. In: McCance RA, Widdowson EM, eds. Calorie deficiencies and protein deficiencies. London, United Kingdom: Churchill, 1968:48-58.
6. Lin CA, Boslaugh S, Ciliberto HM, et al. A prospective assessment of food and nutrient intake in a population of Malawian children at risk for kwashiorkor. J Pediatr Gastroenterol Nutr 2007;44:487-93.
7. Hendrickse RG. Of sick turkeys, kwashiorkor, malaria, perinatal mortality, heroin addicts and food poisoning: research on the influence of aflatoxins on child health in the tropics. Ann Trop Med Parasitol 1997;91:787-93.
8. Ciliberto H, Ciliberto M, Briend A, Ashorn P, Bier D, Manary M. Antioxidant supplementation for the prevention of kwashiorkor in Malawian children: randomised, double blind, placebo controlled trial. BMJ 2005;330:1109-14.
9. Golden MH, Brooks SE, Ramdath DD, Taylor E. Effacement of glomerular foot processes in kwashiorkor. Lancet 1990;336:1472-4.
10. Mohanram M, Reddy V. Urinary excretion of acid mucopolysaccharides in kwashiorkor and vitamin A-deficient children. Clin Chim Acta 1971;34:93-6.
11. Ittyerah TR. Urinary excretion of sulfate in kwashiorkor. Clin Chim Acta 1969;25:365-9.
12. Chandrasekaran EV, Mukherjee KL, Bachhawat BK. Isolation and characterization of glycosaminoglycans from brain of children with protein-calorie malnutrition. J Neurochem 1971;18:1913-20.
13. Gunston GD, Burkimsher D, Malan H, Sive AA. Reversible cerebral shrinkage in kwashiorkor: an MRI study. Arch Dis Child 1992;67:1030-2.
14. Murch SH, Winyard PJD, Koletzko S, et al. Congenital enterocyte heparan sulfate deficiency is associated with massive albumin loss, secretory diarrhea and malnutrition. Lancet 1996;347:1299-301.
15. Westphal V, Murch S, Kim S, et al. A congenital disorder of glycosylation (CDG-Ic) impairs heparan sulfate proteoglycan accumulation in small intestine epithelial cells and contributes to protein-losing enteropathy. Am J Pathol 2000;157:1917-25.
16. Bode L, Eklund EA, Murch SH, Freeze HH. Heparan sulfate loss causes protein leakage and amplifies TNFα-response in an in vitro model of protein-losing enteropathy. Am J Physiol Gastrointest Liver Physiol 2005;288:G1015-23.
17. Bode L, Murch S, Freeze HH. Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy. J Biol Chem 2006;281:7809-15.
18. Bode L, Salvestrini C, Park PW, et al. Heparan sulfate and syndecan-1 are essential in maintaining intestinal epithelial barrier function. J Clin Invest 2008;118:229-38.
19. Lencer WI. Patching a leaky intestine. N Engl J Med 2008;359:526-8.
20. Amadi B, Mwiya M, Chomba E, et al. Improved nutritional recovery on an elemental diet in Zambian children with persistent diarrhea and malnutrition. J Trop Pediatr 2005;51:5-10.
21. Classification of infantile malnutrition. Lancet 1970;296:302-3.
22. Campbell DI, Murch SH, Lunn PG, et al. Chronic T cell-mediated enteropathy in rural West African children: Relationship with nutritional status and small bowel function. Pediatr Res 2003;54:306-11.
23. David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 1992;119:961-75.
24. Bishop JR, Schuksz M, Esko JD. Heparan sulfate proteoglycans fine-tune mammalian physiology. Nature 2007;446:1030-7.
25. Murch SH, MacDonald TT, Walker-Smith JA, Levin M, Lionetti P, Klein NJ. Disruption of sulfated glycosaminoglycans in intestinal inflammation. Lancet 1993;341:711-4.
26. Dossetor J. Persistent intestinal protein loss after measles. BMJ 1976;2:1231.
27. Shukry AS, Gabr M, Sallam F, Saadani M. Protein-losing gastro-enteropathy in kwashiorkor. J Trop Med Hyg 1965;68:269-71.
28. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr 2006;136:2127-30.
29. De Foliart GR. Insects as food: why the Western attitude is important. Annu Rev Entomol 1999;44:21-50.
30. Luyendyk JP, Copple BL, Barton CC, Ganey PE, Roth RA. Augmentation of aflatoxin B1 hepatotoxicity by endotoxin: involvement of endothelium and the coagulation system. Toxicol Sci 2003;72:171-81.
31. Karlsson K, Lindahl U, Marklund SL. Binding of human extracellular superoxide dismutase C to sulfated glycosaminoglycans. Biochem J 1988;256:29-33.
32. Bode L, Freeze HH. Applied glycoproteomics-approaches to study genetic-environmental collisions causing protein-losing enteropathy. Biochim Biophys Acta 2006;1760:547-59.
33. Jahoor F, Badaloo A, Reid M, Forrester T. Protein metabolism in severe childhood malnutrition. Ann Trop Paediatr 2008;28:87-101.
34. Agbedana EO, Johnson AO, Taylor GO. Studies on hepatic and extra-hepatic lipoprotein lipases in protein-calorie malnutrition. Am J Clin Nutr 1979;32:292-8.
35. Kolset SO, Salmivirta M. Cell surface heparan sulfate proteoglycans and lipoprotein metabolism. Cell Mol Life Sci 1999;56:857-70.
36. MacArthur JM, Bishop JR, Stanford KI, et al. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 2007;117:153-64.
37. Milstone LM, Hough-Monroe L, Kugelman LC, Bender JR, Haggerty JG. Epican, a heparan/chondroitin sulfate proteoglycan form of CD44,mediates cell-cell adhesion. J Cell Sci 1994;107:3183-90.
38. Hird RB, Crawford FA, Spinale FG. Differential effects of protamine sulfate on myocyte contractile function with left ventricular failure. J Am Coll Cardiol 1995;25:773-80.
39. Karli J, Stamatelopoulos S, Karikas G, Levis G, Moulopoulos S. Effect of heparin on myocardial contractility of the dog and on Na, K-ATPase. Res Commun Chem Pathol Pharmacol 1984;43:79-96.
40. Reizes O, Clegg DJ, Strader AD, Benoit SC. A role for syndecan-3 in the melanocortin regulation of energy balance. Peptides 2006;27:274-80.
41. Ishiguro K, Kadomatsu K, Kojima T, et al. Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice. J Biol Chem 2001;276:47483-8.
42. Vogt AM, Pettersson F, Moll K, et al. Release of sequestered malaria parasites upon injection of a glycosaminoglycan. PLoS Pathog 2006;2:e100.
43. Heddini A, Pettersson F, Kai O, et al. Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect Immun 2001;69:5849-56.
44. Kirn TJ, Jude BA, Taylor RK. A colonization factor links Vibrio cholerae environmental survival and human infection. Nature 2005;438:863-6.
45. Bobardt MD, Salmon P, Wang L, et al. Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion. J Virol 2004;78:6567-84.
46. Kessler L, Daley H, Malenga G, Graham S. The impact of the human immunodeficiency virus type 1 on the management of severe malnutrition in Malawi. Ann Trop Paediatr 2000;20:50-6.
47. Angami K, Reddy SV. Singh KhI, Singh NB, Singh PI. Prevalence of HIV infection and AIDS symptomatology in malnourished children: a hospital based study. J Commun Dis 2004;36:45-52.
48. Bachou H, Tylleskar T, Downing R, Tumwine JK. Severe malnutrition with and without HIV-1 infection in hospitalised children in Kampala, Uganda: differences in clinical features, haematological findings and CD4+ cell counts. Nutr J 2006;5:27.
49. Esko JD, Selleck SB. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 2002;71:435-71.
50. Salvatore S, Heuschkel RB, Tomlin S, et al. Therapeutic efficacy of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in chronic inflammatory bowel disease. Aliment Pharmacol Ther 2000;14:1567-79.